financetom
Business
financetom
/
Business
/
NewMarket Q3 Earnings, Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NewMarket Q3 Earnings, Sales Decline
Oct 31, 2025 1:37 AM

04:25 AM EDT, 10/31/2025 (MT Newswires) -- NewMarket (NEU) reported late Thursday Q3 earnings of $10.67 per share, down from $13.79 per share a year earlier.

Sales for the quarter ended Sept. 30 were $690.3 million, down from $724.9 million a year earlier.

Analysts' estimates were not available for comparison.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AngloGold Ashanti Divests Stake in G2 Goldfields
AngloGold Ashanti Divests Stake in G2 Goldfields
Jul 9, 2025
08:50 AM EDT, 07/09/2025 (MT Newswires) -- AngloGold Ashanti Holdings said Wednesday that it sold its entire 15% stake in G2 Goldfields ( GUYGF ) . AngloGold didn't say at what price it sold its 35.9 million G2 common shares. G2, which is developing the Aurora gold project in Guyana, dropped 6% on Tuesday to $2.67 on the TSX. ...
Revolution Medicines, Iambic Therapeutics Form AI-Powered Drug Discovery Partnership
Revolution Medicines, Iambic Therapeutics Form AI-Powered Drug Discovery Partnership
Jul 9, 2025
08:49 AM EDT, 07/09/2025 (MT Newswires) -- Revolution Medicines ( RVMD ) and Iambic Therapeutics said Wednesday they have entered a multi-year agreement to discover new drug candidates using AI-driven models. Under the agreement, Iambic will train customized versions of its AI models using proprietary structures and molecular libraries provided by Revolution Medicines ( RVMD ), the company said. Both...
Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions
Update: Market Chatter: CVS Health's Omnicare Ordered to Pay $948.8 Million Over Invalid Prescriptions
Jul 9, 2025
08:49 AM EDT, 07/09/2025 (MT Newswires) -- (Updates with the company statement from the third paragraph.) CVS Health's ( CVS ) Omnicare unit was ordered to pay $948.8 million in penalties and damages in a whistleblower lawsuit alleging it fraudulently billed the US government for invalid drug prescriptions, Reuters reported Tuesday, citing a court order. US District Judge Colleen McMahon...
Copyright 2023-2026 - www.financetom.com All Rights Reserved